- ASSISTANT CLINICAL PROFESSOR Psychiatry
Psychiatry, American Board of Psychiatry and Neurology
- Adjustment Disorder
- Attention Deficit Hyperactivity Disorder And Attention Deficit Disorder
- Bipolar Disorder
- Body Dysmorphic Disorder
- Cognitive-Behavioral Therapy (CBT)
- Exposure-Response Prevention
- Generalized Anxiety Disorder
- Impulse Control Disorders
- Obsessive-Compulsive Disorder
- Panic Disorder
- Post-Traumatic Stress Disorder
- Premenstrual Dysphoric Disorder
- Seasonal Affective Disorder
- Social Anxiety Disorder
- Specific Phobias
- Tourette Syndrome
MD, George Washington University
Mount Sinai Hospital
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Steinberg did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.